KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Liabilities and Shareholders Equity (2016 - 2025)

LifeMD (LFMD) has disclosed Liabilities and Shareholders Equity for 14 consecutive years, with $70.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 7.47% year-over-year to $70.4 million, compared with a TTM value of $283.6 million through Dec 2025, up 3.52%, and an annual FY2025 reading of $70.4 million, down 7.47% over the prior year.
  • Liabilities and Shareholders Equity was $70.4 million for Q4 2025 at LifeMD, up from $66.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $76.1 million in Q4 2024 and bottomed at $16.4 million in Q3 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $47.9 million, with a median of $45.3 million recorded in 2021.
  • The sharpest move saw Liabilities and Shareholders Equity surged 718.13% in 2021, then tumbled 48.59% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $49.9 million in 2021, then tumbled by 48.59% to $25.7 million in 2022, then soared by 127.85% to $58.5 million in 2023, then soared by 30.12% to $76.1 million in 2024, then decreased by 7.47% to $70.4 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for LFMD at $70.4 million in Q4 2025, $66.0 million in Q3 2025, and $73.6 million in Q2 2025.